Short Interest in iShares Health Innovation Active ETF (NYSEARCA:BMED) Decreases By 49.8%

iShares Health Innovation Active ETF (NYSEARCA:BMED) was the target of a large drop in short interest during the month of May. As of May 15th, there was short interest totaling 3,688 shares, a drop of 49.8% from the April 30th total of 7,345 shares. Currently, 1.0% of the shares of the company are short sold. Based on an average daily volume of 2,572 shares, the short-interest ratio is presently 1.4 days.

Institutional Trading of iShares Health Innovation Active ETF

A hedge fund recently bought a new stake in iShares Health Innovation Active ETF stock. Sunbelt Securities Inc. purchased a new position in shares of iShares Health Innovation Active ETF (NYSEARCA:BMED) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm purchased 11,612 shares of the company’s stock, valued at approximately $352,000. Sunbelt Securities Inc. owned about 3.63% of iShares Health Innovation Active ETF at the end of the most recent quarter.

iShares Health Innovation Active ETF Stock Performance

NYSEARCA:BMED traded down $0.34 during mid-day trading on Monday, hitting $28.39. 1,895 shares of the stock were exchanged, compared to its average volume of 4,315. The stock has a market capitalization of $10.22 million, a price-to-earnings ratio of 24.91 and a beta of 0.75. The firm’s 50-day simple moving average is $28.40 and its 200 day simple moving average is $29.74. iShares Health Innovation Active ETF has a fifty-two week low of $24.20 and a fifty-two week high of $32.19.

About iShares Health Innovation Active ETF

The BlackRock Future Health ETF (BMED) is an exchange-traded fund that is based on the MSCI All Country World index. The fund is actively managed to invest in global equities in the health sciences industry. BMED was launched on Sep 29, 2020 and is managed by BlackRock.